April 20, 2010
The first implantation of the now commercially available Advisa DR MRI™ SureScan™ pacing system has taken place in United Kingdom (UK).
Advisa MRI is Medtronic’s second-generation pacing system in a portfolio of pacing systems designed, tested, and approved for use as labeled with MRI machines in UK.
April 9, 2010
The National Institute for Health and Clinical Excellence (NICE) in England and Wales, has just published a new appraisal consultation document (ACD)1 for Multaq® (dronedarone) indicating its intention to recommend its use for the management of patients with atrial fibrillation (AF).
Log in or Register now.
Sign up for our regular email newsletters & be the first to know about fresh articles and site updates.